From: Tuberculosis screening costs and cost-effectiveness in high-risk groups: a systematic review
Study, year | Country setting | Study population | Screening interventions and diagnostic tools | Reference screening strategies and diagnostic tools | Analysis perspective |
---|---|---|---|---|---|
Abimbola et al. 2012 | South Africa | PLHIV initiating ART | 1) WHO 4SS; SSM; SM (−) followed by CXR; CXR (−) followed by culture 2) WHO 4SS; Xpert for diagnosis | Standard practice: SSM; SM (−) followed by CXR | Health system |
Adelman et al. 2017 | Ethiopia | PLHIV in HIV clinics | WHO 4SS; Xpert for diagnostic test of PLHIV with positive symptom screen (i.e. at least 1 symptom); Xpert( +) then DST/culture | Current recommended practice: 4SS, the SM and/or clinical diagnosis of TB | Health system |
Andrews et al. 2012 | South Africa | ARV naïve, PLHIV | Initial WHO 4SS then: 1) SSM (2 samples)—Xpert in TB-symptomatic; 2) SSM (2)—Xpert in all; 3) Culture (2)—Xpert in TB-symptomatic; 4) Culture (2)—Xpert in all; 5) Xpert (1) in TB-symptomatic; 6) Xpert (1) in all; 7) Xpert (2) in TB-symptomatic; 8) Xpert (2) in all | No TB screening | Health system |
Bassett et al. 2010 | South Africa | PLHIV initiating ART | ICF: WHO 4SS and CXR, then all PLHIV provided sputum for QIAmp (PCR) and culture | Symptoms (cough > 2 weeks) | Health system |
Bogdanova et al. 2019 | Russian Federation | General population, PLHIV, homeless, migrants, chronic medical conditions | 1) Contact tracing done then CXR and SSM for diagnosis; 2) Mass screening in hospitals using CXR and SSM; 3) Mass screening in TB dispensary using mobile CXR then SSM | PCF including CXR and SSM | Health system |
James et al. 2017 | Cambodia | poor, urban residents; elderly living in rural areas | ACF interventions: 1) HOPE—Door-to-door screening WHO 4SS, symptomatic patients SSM (LED), then Xpert and culture; 2) CATA—Door-to-door screening older patients WHO 4SS, if symptomatic referred for CXR screening, if abnormal then Xpert | N/A | Health system |
Ji et al. 2020 | China | Diabetic patients | ACF intervention—Patients received regular physical exams for 3 years; Diabetes patients all WHO 4SS, then positive symptom had CXR, then SSM, SM(-) then culture for TB confirmation | N/A | Health system |
Jit et al. 2011 | United Kingdom | Hard to reach individuals | Find and Treat service: 48 mobile CXR screening units offering: 1) mobile CXR; 2) enhanced case management; 3) referral for loss-to-follow-up | PCF – people passively presenting to hospital | Health system |
Jo et al. 2020 | Cambodia, Tajikistan | Cambodia—elderly, vulnerable groups in rural areas Tajikistan—detention centers and diabetic patients | Cambodia—Community sensitization and training of CHWs, door-to-door WHO 4SS by CHWS, all patients had mobile CXR, abnormal CXR then Xpert Tajikistan—Community sensitization and training of TB staff, CHWs used mobile-phone questionnaire at health facilities WHO 4SS followed by CXR, SSM then Xpert based on SSM results | N/A | Health system |
Karki et al. 2017 | Papua New Guinea | General population in rural villages | Outreach visits to villages: Systematic 4SS throughout villages, if symptomatic then SSM | N/A | Health system |
Kranzer et al. 2012 | South Africa | Peri-urban population attending mobile testing | Mobile HIV testing van added TB testing: WHO 4SS for all HIV(-), if symptomatic then SSM; all HIV + SSM and referral to TB clinic for evaluation including CXR | N/A | Health system |
Machekera et al. 2019 | Zimbabwe | High-risk groups: PLHIV, contacts, miners, HCW, prisoners, elderly | Zimbabwe ACF: WHO 4SS, then all have CXR, if either 4SS or CXR positive then Xpert with clinical diagnosis, if needed | WHO algorithms: WHO2b: 4SS, if positive then Xpert and clinical diagnosis, if needed WHO2d: 4SS, if positive then CXR, then Xpert then clinical diagnosis WHO3b: CXR, then Xpert and clinical diagnosis, if needed | Health system |
Maheswaran et al. 2012 | Sub-Saharan Africa | PLHIV | 1) Any classic symptom; 2) 2 + classic symptoms; 3) CXR on all; 4) SSM on all; 5) 4SS, if positive then CXR; 6) 4SS, if positive then SSM; 7) 4SS, if positive then SSM then CXR; 8) 4SS if positive then CXR then SSM | Chronic cough > 2 weeks | Health system |
Murray et al. 2016 | Uganda | General population | WHO 4SS, if cough > 2 weeks then triage testing with CXR or CRP then Xpert for diagnosis | PCF (baseline scenario): WHO 4SS, no triage testing, if symptomatic then Xpert | Health system |
Orlando et al. 2018 | Mozambique | PLHIV | 1) Xpert: Xpert for all participants; 2) LAM: urine TB-LAM in all patients with CD4 < 200; Xpert in all patients with CD4 > 200 and TB-LAM(-) with CD4 < 200 | Standard: WHO 4SS, if symptomatic then SSM | Health system |
Reddy et al. 2019 | Malawi, South Africa | Hospitalized PLHIV | ICF intervention: Sputum Xpert, urine LAM and urine Xpert Modified intervention: Sputum Xpert and TB-LAM | Standard of care: Xpert | Health system |
Sekandi et al. 2015 | Uganda | HHC, urban population | 1) PCF + ACF: HCW perform door-to-door chronic cough surveys (> 2 weeks) then collect 2 sputum for SSM, then return test results to the patient at their home; 2) PCF + HHC investigations (HCI): HCW perform WHO 4SS to HHC in home; child contacts and those unable to produce sputum diagnosed using CXR | PCF: Self-referral or presenting to health facility, chronic cough (> 2 weeks). WHO 4SS then SSM, if unable to produce sputum then diagnosed using CXR | Health system, societal perspective |
Shah et al. 2017 | Peru | HHC (low HIV incidence setting) | 1) ACF: PCF + HCW visits to screen HHC using WHO 4SS and SSM; 2) PCF + Xpert; 3) ACF + Xpert: HCW visits to screen HHC using WHO 4SS and Xpert for diagnosis | PCF: Self-referral or presenting to health facility, TB diagnosis using SSM and clinical evaluation | Health system |
Shah et al. 2009 | Ethiopia | PLHIV (18 + years) in VCT clinic | 1) WHO 4SS then SSM, if SM(-) then CXR; 2) CXR for all PLHIV at entry, if CXR( +) then SSM | N/A | Health system |
Shah et al. 2008 | Vietnam | PLHIV | All PLHIV screened using CXR (all diagnosed HIV + before CXR), confirmed diagnosis with SSM | N/A | Health system |
Smit et al. 2017 | Belgium | High risk groups and contacts (asylum seekers and migrants) | Systematic screening in high-risk groups including WHO 4SS and CXR; Follow-up of asylum seekers with abnormal CXR, supplemental CXR and periodic screening (6/12 months) after arrival | N/A | Health system |
Sohn et al. 2019 | India | Rural, tribal population | CHW visits to homes with TB education, screening: WHO 4SS and SSM, CHW return with results | N/A | Health system |
Winestsky et al. 2012 | Russian Federation | Prisoners | 1) CXR screening; 2) WHO 4SS; 3) Annual Xpert screening; 4) WHO 4SS + CXR; 5) CXR + Xpert; 6) WHO 4SS + Xpert; 7) WHO 4SS + CXR + Xpert DST used for treatment planning | PCF: No screening (self-referral) | Health system |
Yoon et al. 2019 | Uganda | PLHIV in two HIV clinics | Novel ICF algorithms: 1) WHO 4SS + TB-LAM + Xpert; 2) WHO 4SS + TB-LAM + Xpert + culture; 3) POC CRP + Xpert; 4) POC CRP + TB-LAM + Xpert; 5) POC CRP + TB-LAM + Xpert + culture | Current ICF: WHO 4SS, if symptomatic then Xpert for diagnosis | Health system |
Zhang et al. 2016 | China | High risk groups including elderly (65 +) | 1) WHO A1: WHO 4SS, if cough > 2 weeks then CXR, if CXR( +) then SSM; 2) WHO A1B: WHO 4SS, if cough > 2 weeks then CXR, if CXR( +) then SSM; 3) WHO A2: WHO 4SS, if any TB symptoms then CXR, if CXR( +) then SSM; 4) WHO A3: Screening with CXR, if CXR( +) then SSM | N/A | Health system |
Zishiri et al. 2014 | South Africa | Correctional facility inmates | WHO 4SS questionnaire for all newly admitted inmates, 1 + symptoms then diagnosed with Xpert | N/A | Health system |
Zwerling et al. 2015 | Malawi | Newly diagnosed PLHIV in rural Malawi | Initial WHO 4SS, if 1 or more TB symptoms, then LED or Xpert; If initial 4SS negative, then patient asked to return 1 month later for second test if still symptomatic; Diagnosis with SSM, LED and Xpert | Standard of care (i.e. discretion of treating physician) using SSM | Health system |